Growing vertical aligned mesoporous silica thin film on nanoporous substrate for enhanced degradation, drug delivery and bioactivity.
Bioact Mater
; 6(5): 1452-1463, 2021 May.
Article
de En
| MEDLINE
| ID: mdl-33251381
Mesoporous silica thin film has been widely used in various fields, particularly the medical implant coating for drug delivery. However, some drawbacks remain with the films produced by traditional method (evaporation-induced self-assembly, EISA), such as the poor permeability caused by their horizontal aligned mesochannels. In this study, the vertical aligned mesoporous silica thin film (VMSTF) is uniformly grown alongside the walls of titania nanotubes array via a biphase stratification growth method, resulting in a hierarchical two-layered nanotubular structure. Due to the exposure of opened mesopores, VMSTF exhibits more appealing performances, including rapid degradation, efficient small-molecular drug (dexamethasone) loading and release, enhanced early adhesion and osteogenic differentiation of MC3T3-E1 cells. This is the first time successfully depositing VMSTF on nanoporous substrate and our findings suggest that the VMSTF may be a promising candidate for bone implant surface coating to obtain bioactive performances.
ALP, alkaline phosphatase; DEX, dexamethasone; Drug delivery; HAP, hydroxylapatite nanoparticles; HMSTF, hybrid organic-inorganic MSTF; MSTF, mesoporous silica thin film; Mesoporous silica film; OCN, osteocalcin; OPN, osteopontin; Osteoblasts; PMSTF, parallel aligned MSTF; PT, polished titanium; RUNX2, runt-related transcription factor 2; TNN, titania nanonet; TNT, titania nanotube; Titania nanotubes array; TiOH, hydroxylated titanium; VMSTF, vertical aligned MSTF; Vertical aligned mesochannels
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Langue:
En
Journal:
Bioact Mater
Année:
2021
Type de document:
Article
Pays d'affiliation:
Chine
Pays de publication:
Chine